Dermatology · Ponchatoula, LA
NPI
1932542198
Since 2013
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
180 N 5th St
Ponchatoula, LA, 70454
Phone (985) 370-7546
Groups this clinician bills Medicare through
Medicare paid, 2024
$174K
2,324 services
Medicare patients, 2024
303
Average age 74
Drug cost, 2024
$820K
1,468 prescriptions
Company payments, 2025
$997
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Falon V Brown was code 17003 (destruction skin lesion), 829 times for 132 patients. In total Falon V Brown billed 2,324 services in 42 codes, and Medicare paid $174K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 829 | 132 | $4.38 | $3,635 |
| 99213 Office E&M - Established | Office | 323 | 204 | $57.38 | $19K |
| 17000 Destruction Skin Lesion | Office | 251 | 162 | $34.48 | $8,655 |
| 99214 Office E&M - Established | Office | 208 | 132 | $81.36 | $17K |
| 17108 Destruction Skin Lesion | Office | 160 | 33 | $456.62 | $73K |
| 11102 Skin Biopsy | Office | 142 | 118 | $58.08 | $8,248 |
| 17110 Destruction Skin Lesion | Office | 73 | 55 | $73.52 | $5,367 |
| 11103 Skin Biopsy | Office | 59 | 41 | $33.74 | $1,991 |
| J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 51 | 31 | $310.37 | $16K |
| 96574 Skin | Office | 48 | 30 | $178.71 | $8,578 |
| 99212 Office E&M - Established | Office | 34 | 25 | $37.70 | $1,282 |
| 17004 Destruction Skin Lesion | Office | 15 | 11 | $118.55 | $1,778 |
By year: 2022 $130K for 1,605 services; 2023 $144K for 1,915 services; 2024 $174K for 2,324 services.
Medicare prescription drug claims, 2024
In 2024, the drug Falon V Brown prescribed most often to Medicare patients was Ketoconazole, with 293 prescriptions and refills. In total Falon V Brown wrote 1,468 Medicare prescriptions that cost $820K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 293 | 304 | 109 | $4,800 |
| Triamcinolone Acetonide Generic | 81 | 91 | 64 | $842 |
| Mupirocin Generic | 73 | 73 | 59 | $520 |
| Doxycycline Hyclate Generic | 73 | 103 | 39 | $1,318 |
| Dupixent Pen Dupilumab | 66 | 66 | Under 11 | $246K |
| Clobetasol Propionate Generic | 63 | 63 | 44 | $1,943 |
| Ammonium Lactate Generic | 62 | 73 | 30 | $1,387 |
| Metronidazole Generic | 60 | 73 | 40 | $2,887 |
| Imiquimod Generic | 49 | 64 | 29 | $1,527 |
| Hydrocortisone Generic | 41 | 41 | 28 | $254 |
| Valacyclovir Valacyclovir Hcl | 40 | 56 | 28 | $1,041 |
| Minoxidil Generic | 38 | 86 | 12 | $268 |
| Hydroxychloroquine Sulfate Generic | 35 | 47 | Under 11 | $924 |
| Pimecrolimus Generic | 31 | 35 | Under 11 | $16K |
| Ciclopirox Generic | 28 | 28 | 12 | $1,083 |
Brand drugs: 196 claims; generic drugs: 1,272 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Falon V Brown $997 ($997 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $325.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 29 | $325 |
| UCB, Inc. UCB.BR | 3 | $96.43 |
| Pfizer Inc. PFE | 5 | $96.08 |
| Janssen Biotech, Inc. JNJ | 4 | $68.62 |
| Amgen Inc. AMGN | 3 | $64.57 |
| LEO Pharma Inc. | 3 | $60.14 |
| Galderma Laboratories, L.P. GALD.SW | 3 | $57.54 |
| Genzyme Corporation SNY | 2 | $41.67 |
| Botanix SB Inc | 2 | $38.68 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $30.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.